Svoboda Frank M's Form 4/A amendment
AmendedGlobe Life Inc. (GL) · filed Apr 30, 2024
- Accession no.
- 0001062993-24-009055
- Filed
- Apr 30, 2024
- Trade date
- Nov 17, 2023
- Filing delay
- 165 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Nov 20, 2023
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.12M. It was filed 165 days after the trade.
This amendment replaces 0001062993-23-021180 (filed Nov 20, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Svoboda Frank MCIK 0001270842 | Director, Officer (Co-Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2023 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Sales at prices ranging from $118.10 per share to $118.34 per share.
Referenced by the price of 1 transaction in Table I.
- F2
Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
Referenced by the price of 1 transaction in Table I.
- F3
Shares in unitized fund in Company's 401(k) employee benefit plan - estimated conversion of $ balance to shares using $118.30 per share.